0001707212-19-000001.txt : 20190625 0001707212-19-000001.hdr.sgml : 20190625 20190625111746 ACCESSION NUMBER: 0001707212-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190625 DATE AS OF CHANGE: 20190625 EFFECTIVENESS DATE: 20190625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orpheus Bioscience, Inc. CENTRAL INDEX KEY: 0001707212 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-342680 FILM NUMBER: 19917434 BUSINESS ADDRESS: STREET 1: 9385 DISCOVERY BLVD. #115 CITY: MANASSAS STATE: VA ZIP: 20109 BUSINESS PHONE: (212) 692-6758 MAIL ADDRESS: STREET 1: 9385 DISCOVERY BLVD. #115 CITY: MANASSAS STATE: VA ZIP: 20109 D 1 primary_doc.xml X0708 D LIVE 0001707212 Orpheus Bioscience, Inc. 9385 DISCOVERY BLVD. #115 MANASSAS VA VIRGINIA 20109 (212) 692-6758 DELAWARE None None Corporation true 2017 Guy Yachin c/o Orpheus Bioscience, Inc. 9385 Discovery Blvd., Suite 115 Manassas VA VIRGINIA 20109 Executive Officer Director John Abeles c/o Orpehus Bioscience, Inc. 9385 Discovery Blvd., Suite 115 Manassas VA VIRGINIA 20109 Director Cohava Gelber c/o Orpehus Bioscience, Inc. 9385 Discovery Blvd., Suite 115 Manassas VA VIRGINIA 20109 Director Other Decline to Disclose 06b false 2019-06-11 false true true false 0 David Lanskowsky 4221686 GP Nurmenkari Inc. 153480 64 Wall Street, Suite 402 Norwalk CT CONNECTICUT 06850 All States false 5000550 3157125 1843425 false 38 315712 true 0 In addition to cash compensation, a sales commission in the form of warrants to acquire shares of the Issuer is issued based on a percentage of shares sold. 0 false Orpheus Bioscience, Inc. /s/ Guy Yachin Guy Yachin President 2019-06-25